Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Stem cell treatments may improve burn wound healing.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

A pregnant woman with Cushing Syndrome got worse and sadly passed away.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.